Oral administration of porcine liver decomposition product for 4weeks enhances visual memory and delayed recall in healthy adults over 40years of age: A randomized, double-blind, placebo-controlled study.

Abstract

Porcine liver decomposition product (PLDP) contains neurofunctional phospholipids. We previously reported that PLDP enhances cognitive function in healthy adult humans, based on clinical evaluations using Hasegawa's Dementia Scale-Revised. In this study, we evaluated the effect of PLDP on memory indicators of the Wechsler Memory Scale-Revised (WMS-R), an internationally recognized battery for memory assessment. We conducted a double-blind parallel-group placebo-controlled trial to evaluate the effect of PLDP on memory. Fifty-eight participants competed the trial: 28 participants were in the PLDP group and 30 participants were in the placebo group. Each group was administered PLDP (4 capsules) or a placebo (4 capsules) for 4 continuous weeks. WMS-R was administered before and 4weeks after PLDP or placebo intake. The data were also subdivided by age for participants under 40years (N=15 in PLDP; N=15 in placebo) and over 40years (N=13 in PLDP, N=15 in placebo). Changes in Verbal Memory, Visual Memory, Attention/Concentration, and Delayed Recall were analyzed. No significant differences were found in any memory indicators between the PLDP group and the placebo group in pooled participants and in participants under 40years of age. However, for participants over 40years of age, PLDP administration resulted in a significant enhancement than placebo administration in Delayed Recall (14.1±7.1 points vs. 7.1±6.8 points) (P<0.05), Visual Recall I (20.1±23.1 percentile vs 1.9±22.8 percentile) (P<0.05), and Visual Recall II (24.2±25.8 percentile vs 6.7±19.0 percentile) (P<0.05), respectively. The composition ratio of men to women in each group was imbalanced but no significant difference existed between the two groups. A modest sample size, single-center design, and a fairly short follow-up period. PLDP enhanced Visual Memory and Delayed Recall in healthy adults over 40years of age but not in healthy adults under 40years of age. Therefore, PLDP may represent a promising nutraceutical that could improve cognitive function in healthy adults over 40years of age. Further studies are required to evaluate if long term PLDP administration can prevent or delay cognitive dysfunction in healthy adults over 40years of age.